RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders

RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics as well as Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders

NEWTON, MA as well as GENEVA, SWITZERLAND/ ACCESSWIRE/ August 9, 2021/ Acer Therapeutics Inc. (NASDAQ: ACER) (” Acer “), a pharmaceutical firm concentrated on the purchase, advancement as well as commercialization of treatments for significant unusual as well as deadly disea …

Read More …